ADAMTS18 has been reported to have tumor suppressor activity in esophageal adenocarcinoma, nasopharyngeal carcinoma, colorectal carcinoma, breast carcinoma, lung carcinoma, cervical carcinoma, and clear cell renal cell carcinoma (19, 28, 42–45). The gene discussed is ADAMTS18; the disease is clear cell renal carcinoma.